143 related articles for article (PubMed ID: 7492082)
1. Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamine.
Merali S; Chin K; Grady RW; Weissberger L; Clarkson AB
Antimicrob Agents Chemother; 1995 Jul; 39(7):1442-4. PubMed ID: 7492082
[TBL] [Abstract][Full Text] [Related]
2. Action of deferoxamine against Pneumocystis carinii.
Clarkson AB; Turkel-Parrella D; Williams JH; Chen LC; Gordon T; Merali S
Antimicrob Agents Chemother; 2001 Dec; 45(12):3560-5. PubMed ID: 11709340
[TBL] [Abstract][Full Text] [Related]
3. Clinically achievable plasma deferoxamine concentrations are therapeutic in a rat model of Pneumocystis carinii pneumonia.
Merali S; Chin K; Del Angel L; Grady RW; Armstrong M; Clarkson AB
Antimicrob Agents Chemother; 1995 Sep; 39(9):2023-6. PubMed ID: 8540710
[TBL] [Abstract][Full Text] [Related]
4. Deferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia.
Clarkson AB; Sarić M; Grady RW
Antimicrob Agents Chemother; 1990 Sep; 34(9):1833-5. PubMed ID: 2285303
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of DL-alpha-difluoromethylornithine and improved efficacy against a rat model of Pneumocystis carinii pneumonia.
Chin K; Merali S; Sarić M; Clarkson AB
Antimicrob Agents Chemother; 1996 Oct; 40(10):2318-20. PubMed ID: 8891137
[TBL] [Abstract][Full Text] [Related]
6. Trophozoite elimination in a rat model of Pneumocystis carinii pneumonia by clinically achievable plasma deferoxamine concentrations.
Merali S; Chin K; Grady RW; Clarkson AB
Antimicrob Agents Chemother; 1996 May; 40(5):1298-300. PubMed ID: 8723489
[TBL] [Abstract][Full Text] [Related]
7. Iron chelators as therapeutic agents against Pneumocystis carinii.
Weinberg GA
Antimicrob Agents Chemother; 1994 May; 38(5):997-1003. PubMed ID: 8067783
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.
Queener SF; Dean RA; Bartlett MS; Milhous WK; Berman JD; Ellis WY; Smith JW
J Infect Dis; 1992 Apr; 165(4):764-8. PubMed ID: 1532406
[TBL] [Abstract][Full Text] [Related]
9. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.
Boylan CJ; Current WL
Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080
[TBL] [Abstract][Full Text] [Related]
10. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.
Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C
J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168
[TBL] [Abstract][Full Text] [Related]
11. Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.
Walzer PD; Foy J; Runck J; Steele P; White M; Klein RS; Otter BA; Sundberg RJ
Antimicrob Agents Chemother; 1994 Nov; 38(11):2572-6. PubMed ID: 7872750
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.
Clarkson AB; Williams DE; Rosenberg C
Antimicrob Agents Chemother; 1988 Aug; 32(8):1158-63. PubMed ID: 3142346
[TBL] [Abstract][Full Text] [Related]
13. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
Walzer PD; Foy J; Steele P; White M
Antimicrob Agents Chemother; 1993 Jul; 37(7):1436-43. PubMed ID: 8363372
[TBL] [Abstract][Full Text] [Related]
14. Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats.
Kluge RM; Spaulding DM; Spain AJ
Antimicrob Agents Chemother; 1978 Jun; 13(6):975-8. PubMed ID: 307941
[TBL] [Abstract][Full Text] [Related]
15. Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
Hughes WT; Killmar J
Antimicrob Agents Chemother; 1996 Apr; 40(4):962-5. PubMed ID: 8849260
[TBL] [Abstract][Full Text] [Related]
16. Clinically achievable plasma deferoxamine concentrations eliminate Pneumocystis carinii trophozoites in a rat model.
Merali S; Chin K; Grady RW; Clarkson AB
J Eukaryot Microbiol; 1996; 43(5):52S. PubMed ID: 8822854
[No Abstract] [Full Text] [Related]
17. Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.
D'Antonio RG; Johnson DB; Winn RE; van Dellen AF; Evans ME
Antimicrob Agents Chemother; 1986 Feb; 29(2):327-9. PubMed ID: 3487285
[TBL] [Abstract][Full Text] [Related]
18. Structural changes in rat Pneumocystis carinii surface antigens after terbinafine administration in experimental P. carinii pneumonia.
Contini C; Angelici E; Canipari R
J Antimicrob Chemother; 1999 Feb; 43(2):301-4. PubMed ID: 11252340
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii.
Young LS
Rev Infect Dis; 1982; 4(2):608-13. PubMed ID: 6981177
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
Hughes WT
Antimicrob Agents Chemother; 1988 May; 32(5):623-5. PubMed ID: 3260765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
